ZKSCAN3 and colorectal carcinoma: The mutation-caused reduction in the luciferase activity of the mutated ZKSCAN3 binding site in the two colorectal carcinoma cell lines was significantly higher compared to the reduction in the Hep3B cell line (Figure 4D).